(en) Ruiz M, Okada H, Dahlbäck B, « HDL-associated ApoM is anti-apoptotic by delivering sphingosine 1-phosphate to S1P1 & S1P3 receptors on vascular endothelium », Lipids Health Dis, vol. 16, no 1, , p. 36. (PMID28179022, PMCIDPMC5299634, DOI10.1186/s12944-017-0429-2, lire en ligne)
(en) Christoffersen C, Nielsen LB, Axler O, Andersson A, Johnsen AH, Dahlbäck B, « Isolation and characterization of human apolipoprotein M-containing lipoproteins », J Lipid Res, vol. 47, no 8, , p. 1833–43. (PMID16682745, DOI10.1194/jlr.M600055-JLR200, lire en ligne)
(en) Elsøe S, Ahnström J, Christoffersen C et al., « Apolipoprotein M binds oxidized phospholipids and increases the antioxidant effect of HDL », Atherosclerosis, vol. 221, no 1, , p. 91–7. (PMID22204862, DOI10.1016/j.atherosclerosis.2011.11.031, lire en ligne)
(en) Liu M, Seo J, Allegood J, Bi X et al., « Hepatic apolipoprotein M (apoM) overexpression stimulates formation of larger apoM/sphingosine 1-phosphate-enriched plasma high density lipoprotein », J Biol Chem, vol. 289, no 5, , p. 2801-14. (PMCIDPMC3908412, DOI10.1074/jbc.M113.499913, lire en ligne)
(en) Ruiz M, Okada H, Dahlbäck B, « HDL-associated ApoM is anti-apoptotic by delivering sphingosine 1-phosphate to S1P1 & S1P3 receptors on vascular endothelium », Lipids Health Dis, vol. 16, no 1, , p. 36. (PMID28179022, PMCIDPMC5299634, DOI10.1186/s12944-017-0429-2, lire en ligne)
(en) Liu M, Seo J, Allegood J, Bi X et al., « Hepatic apolipoprotein M (apoM) overexpression stimulates formation of larger apoM/sphingosine 1-phosphate-enriched plasma high density lipoprotein », J Biol Chem, vol. 289, no 5, , p. 2801-14. (PMCIDPMC3908412, DOI10.1074/jbc.M113.499913, lire en ligne)
jlr.org
(en) Christoffersen C, Nielsen LB, Axler O, Andersson A, Johnsen AH, Dahlbäck B, « Isolation and characterization of human apolipoprotein M-containing lipoproteins », J Lipid Res, vol. 47, no 8, , p. 1833–43. (PMID16682745, DOI10.1194/jlr.M600055-JLR200, lire en ligne)
(en) Christoffersen C, Nielsen LB, Axler O, Andersson A, Johnsen AH, Dahlbäck B, « Isolation and characterization of human apolipoprotein M-containing lipoproteins », J Lipid Res, vol. 47, no 8, , p. 1833–43. (PMID16682745, DOI10.1194/jlr.M600055-JLR200, lire en ligne)
(en) Elsøe S, Ahnström J, Christoffersen C et al., « Apolipoprotein M binds oxidized phospholipids and increases the antioxidant effect of HDL », Atherosclerosis, vol. 221, no 1, , p. 91–7. (PMID22204862, DOI10.1016/j.atherosclerosis.2011.11.031, lire en ligne)
(en) Liu M, Seo J, Allegood J, Bi X et al., « Hepatic apolipoprotein M (apoM) overexpression stimulates formation of larger apoM/sphingosine 1-phosphate-enriched plasma high density lipoprotein », J Biol Chem, vol. 289, no 5, , p. 2801-14. (PMCIDPMC3908412, DOI10.1074/jbc.M113.499913, lire en ligne)
(en) Ruiz M, Okada H, Dahlbäck B, « HDL-associated ApoM is anti-apoptotic by delivering sphingosine 1-phosphate to S1P1 & S1P3 receptors on vascular endothelium », Lipids Health Dis, vol. 16, no 1, , p. 36. (PMID28179022, PMCIDPMC5299634, DOI10.1186/s12944-017-0429-2, lire en ligne)
(en) Elsøe S, Ahnström J, Christoffersen C et al., « Apolipoprotein M binds oxidized phospholipids and increases the antioxidant effect of HDL », Atherosclerosis, vol. 221, no 1, , p. 91–7. (PMID22204862, DOI10.1016/j.atherosclerosis.2011.11.031, lire en ligne)